ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      57,869.06
      -0.74%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Esperion Therapeutics Inc (ESPR)

      7. Esperion Therapeutics Inc (ESPR) News

      ESPR

      Esperion Therapeutics (ESPR)

      Esperion Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ESPR
      DateTimeSourceHeadlineSymbolCompany
      06/22/20208:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      06/22/20207:00AMGlobeNewswire Inc.Esperion and Daiichi Sankyo Europe Announce Amendment to License and Commercial Collaboration AgreementNASDAQ:ESPREsperion Therapeutics Inc
      06/15/20204:45PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ESPREsperion Therapeutics Inc
      06/14/20209:30AMGlobeNewswire Inc.Esperion Announces Pooled Analysis from Phase 3 LDL-C Lowering Clinical Development Program of NEXLETOL™ (Bempedoic Acid) T...NASDAQ:ESPREsperion Therapeutics Inc
      06/12/20207:19AMGlobeNewswire Inc.Esperion Confirms NEXLETOL™ (bempedoic acid) Tablets to be Included in Assessment of Non-statin Medicines for Hypercholeste...NASDAQ:ESPREsperion Therapeutics Inc
      06/08/20208:00AMGlobeNewswire Inc.Esperion to Participate in Fireside Chat at the Goldman Sachs 41st Annual Global Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      06/04/20207:00AMGlobeNewswire Inc.Esperion Announces Commercial Availability of NEXLIZET™ (bempedoic acid and ezetimibe) Tablets and Ushers in New Era of Ora...NASDAQ:ESPREsperion Therapeutics Inc
      05/29/20204:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      05/29/20204:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      05/29/20204:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      05/29/20204:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      05/29/20204:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      05/29/20204:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      05/29/20204:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      05/29/20204:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      05/29/20204:34PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      05/27/20208:00AMGlobeNewswire Inc.Esperion to Participate in Fireside Chat at the Jefferies Virtual Global Healthcare Conference 2020NASDAQ:ESPREsperion Therapeutics Inc
      05/18/20205:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      05/15/20206:00PMGlobeNewswire Inc.Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ESPREsperion Therapeutics Inc
      05/07/20208:00AMGlobeNewswire Inc.Esperion to Participate in Fireside Chat at the BofA Securities 2020 Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      05/06/20205:28PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ESPREsperion Therapeutics Inc
      05/06/20204:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      05/06/20204:05PMGlobeNewswire Inc.Esperion Reports First Quarter 2020 Financial Results and Provides Company UpdateNASDAQ:ESPREsperion Therapeutics Inc
      04/30/20208:00AMGlobeNewswire Inc.Esperion to Report First Quarter 2020 Financial Results May 6, 2020NASDAQ:ESPREsperion Therapeutics Inc
      04/20/20208:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      04/20/20207:00AMGlobeNewswire Inc.Esperion Announces Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of NEXLETOL™ (bempe...NASDAQ:ESPREsperion Therapeutics Inc
      04/16/20204:31PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ESPREsperion Therapeutics Inc
      04/09/202010:35AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      04/09/20208:00AMGlobeNewswire Inc.Esperion to Participate in Fireside Chat at the 19th Annual Needham Virtual Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      04/06/20207:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ESPR

      Your Recent History

      EU
      REUSE
      BNP Paribas Easy ECPI Ci...
      Delayed Upgrade Clock